CereVasc

CereVasc, Inc. is a clinical-stage medical device company developing novel, minimally invasive treatments for patients with neurological diseases. Its lead product, the eShunt System, uses percutaneous transvenous-transdural access to the central nervous system to treat communicating hydrocephalus — including normal pressure hydrocephalus (NPH) — as a less invasive alternative to conventional neurosurgical shunt placement. The eShunt System is an investigational device limited by United States federal law to investigational use, and is being evaluated in the STRIDE pivotal study (NCT06498960). CereVasc raised a $70M Series B in 2024 and has received FDA Breakthrough Device Designation. The company builds implantable hardware and publishes no public API, developer program, or machine-readable specification.

CereVasc is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Neurology, and Hydrocephalus.

CereVasc’s developer surface includes engineering blog and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesHealthcareNeurologyHydrocephalusMedical TechnologyClinical Stage

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 8.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cerevasc: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cerevasc Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 4

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 BlogRSS
BlogRSS

Other 1

Properties that don't map to a standard resource type

SecondaryMarketListing
SecondaryMarketListing

Source (apis.yml)

apis.yml Raw ↑ 
aid: cerevasc
name: CereVasc
description: CereVasc, Inc. is a clinical-stage medical device company developing novel, minimally invasive treatments for
  patients with neurological diseases. Its lead product, the eShunt System, uses percutaneous transvenous-transdural access
  to the central nervous system to treat communicating hydrocephalus — including normal pressure hydrocephalus (NPH) — as
  a less invasive alternative to conventional neurosurgical shunt placement. The eShunt System is an investigational device
  limited by United States federal law to investigational use, and is being evaluated in the STRIDE pivotal study (NCT06498960).
  CereVasc raised a $70M Series B in 2024 and has received FDA Breakthrough Device Designation. The company builds implantable
  hardware and publishes no public API, developer program, or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/cerevasc/refs/heads/main/apis.yml
image: https://cerevasc.com/wp-content/uploads/2023/10/CereVasc-logo-%C2%AEweb-main.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Medical Devices
- Healthcare
- Neurology
- Hydrocephalus
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cerevasc-domain-security.yml
- type: Website
  url: https://cerevasc.com/
- type: About
  url: https://cerevasc.com/eshunt-system-cerevasc/
- type: Contact
  url: https://cerevasc.com/contact-cerevasc/
- type: Blog
  url: https://cerevasc.com/press/
- type: BlogRSS
  url: https://cerevasc.com/feed/
- type: PrivacyPolicy
  url: https://cerevasc.com/privacy-policy/
- type: SecondaryMarketListing
  url: https://forgeglobal.com/cerevasc_stock/
x-enrichment:
  date: '2026-08-09'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: CereVasc is a clinical-stage neurovascular implant maker whose product is the physical eShunt device; its WordPress
    site has no /developers, /api or /docs path, no api./developer./docs. subdomain resolves in DNS, and every discovery probe
    (/openapi.json, /llms.txt, /.well-known/agent-card.json) returned 404.
  evidence:
  - url: https://cerevasc.com/openapi.json
    status: 404
  - url: https://cerevasc.com/developers
    status: 404
  - url: https://cerevasc.com/llms.txt
    status: 404
  - url: https://cerevasc.com/.well-known/agent-card.json
    status: 404
  - url: https://cerevasc.com/.well-known/security.txt
    status: 404
  - url: https://cerevasc.com/
    status: 200
  checked: '2026-08-09'